Page 1

7 January 2021 Judges Scientific plc ( the " Group " or " Judges " ) Trading Statement and Notice of Final Results The Board of Judges Scientific plc , a group focused on acquiring and developing companies in the scientific instrument sector , provides the following update on the Group's trading performance for the financial year ended 31 December 2020 . As previously disclosed , following the outbreak of Covid - 19 and the subsequent difficult trading conditions associated with lockdowns across the globe , the main impact on the Group has been on order intake which fundamentally drives all other Group key performance metrics . For 2020 , year - on - year Organic¹ order intake receded by 13 % . Notwithstanding this , the Group starts 2021 with a comfortable Organic order book , equivalent to 14.0 weeks of budgeted sales ( 31 December 2019 : 13.2 weeks ) . Strong bookings by the recent acquisitions brings the total order book to 15.5 weeks . The Group delivered significant profit in each month of 2020 and cash generation remained healthy throughout the period . Exchange rates remained favourable throughout the year in spite of Sterling strengthening in the run - up to the conclusion of a trade deal with the EU . In parallel , the Group continued to deliver on its acquisition strategy with the completion of two acquisitions . The Group continues to prioritise the safety of its colleagues , and despite the numerous challenges posed by the pandemic , the Group's performance has remained resilient with the second half of the financial year showing a gradual improvement in our trading environment . As a result , the Board anticipates that Adjusted³ Earnings Per Share for the full year ended 31 December 2020 will be ahead of market expectations . Notice of Final Results Judges expects to announce its full year results for the year ended 31 December 2020 on 23 March 2021 . Notes : 1 . 2 . Organic includes those businesses owned by the Group prior to 1 January 2019 . The 31 December 2020 Organic order book is approximately £ 1.8m lower than December 2019 but shows an increase in the number of weeks of budgeted sales as a result of a more prudent FY2021 budget to reflect COVID uncertainty . 3. Adjusted earnings figures are stated before adjusting items relating to hedging of risks materialising after the end of the period , amortisation of acquired intangible assets , share based payments and acquisition - related costs . 4 . Market consensus Adjusted Earnings Per Share of 151.8p . This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation ( EU ) 596/2014 . The person responsible for making this announcement on behalf of the Company is Brad Ormsby . For further information please contact : Iges Scientific vid Cicurel , CEO Tel : +44 ( 0 ) 20 3829 6970 d Ormsby , Group FD ore Capital ( Nominated Adviser & > ker ) phane Auton Tel : +44 ( 0 ) 20 7408 4090 vard Mansfield ah Mather erum ( Joint Broker ) Tel : +44 ( 0 ) 20 3100 2222